Investigators used thrombolytic nanocages with multivalent clot-targeting peptides and fibrin degradation enzymes, such as microplasmin, to dissolve fibrin in the tumor microenvironment and named them fibrinolytic nanocages.
[Experimental and Molecular Medicine]
7992332
{7992332:BBBBBBBB}
apa
50
1
167958
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/